Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 31Lung Neoplasms 11Head and Neck Neoplasms 5Breast Neoplasms 3Adenocarcinoma of Lung 3Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Prostatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Gliosarcoma 2Glioblastoma 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Brain Neoplasms 2Adenocarcinoma Of Esophagus 2Urinary Bladder Neoplasms 1Untreated Childhood Anaplastic Astrocytoma 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Salivary Gland Neoplasms 1Recurrence 1Pleural Effusion, Malignant 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Neoplasms, Squamous Cell 1Lymphoid Interstitial Pneumonia 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1

Interventions

Carboplatin 6Paclitaxel 5Taxes 3Docetaxel 3Cisplatin 3Gemcitabine 2Erlotinib Hydrochloride 2Drug Therapy 2Bevacizumab 2talimogene laherparepvec 1saracatinib 1romidepsin 1rilotumumab 1ganitumab 1Zoledronic Acid 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Therapeutics 1Talc 1Surveys and Questionnaires 1Spectrum Analysis 1Sodium Chloride 1Pemetrexed 1Nivolumab 1Metformin 1Magnetic Resonance Spectroscopy 1Immunohistochemistry 1Imatinib Mesylate 1Gefitinib 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pleural Effusion, Malignant × Gefitinib × Clear all
NCT00231465 2017-03-03

Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
44 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡